Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2022-12-29 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Amendment Report). It details changes to stock option grants, including the number of shares and the identity of the representative director. In the context of financial filings, reports regarding stock options, share issuance, or capital changes that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under 'Regulatory Filings' (RNS) as a fallback, or specifically as a capital-related disclosure. Given the nature of the filing as a formal regulatory disclosure of corporate action, RNS is the most appropriate classification.
2022-12-29 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically an amendment ('정정신고') to a previous filing. It details changes to the list of employees receiving stock options, the number of shares, and the company's representative director. This type of disclosure regarding stock option grants and their subsequent amendments falls under the category of capital structure and share-related changes, which is best classified as a Regulatory Filing (RNS) in the absence of a more specific 'Stock Option' category, as it is a formal notification to the financial authorities.
2022-12-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis under the Commercial Act. This type of disclosure regarding capital changes and equity-based compensation is classified as a regulatory filing related to share issuance or capital structure changes. Given the specific nature of stock option grants, it falls under the 'Regulatory Filings' (RNS) category as it is a standard corporate disclosure to the financial authorities.
2022-12-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Annual General Meeting). It is not the meeting materials themselves, but a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding corporate governance and meeting preparation, it fits best under the RNS (Regulatory Filings) category as it is a standard corporate disclosure.
2022-12-29 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for SCM Lifescience, covering the period from 2022.01.01 to 2022.09.30. It contains detailed financial information, business operations, management discussion, and corporate governance details, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report (RPA) or a simple regulatory filing (RNS) as it contains substantive financial and operational data. 9M 2022
2022-11-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the 'Regulatory Filings' category as it is a specific corporate disclosure requirement in the Korean market that does not fit into the other specialized categories like 'Director's Dealing' (which is for insider trades) or 'Share Issue' (which is for capital changes).
2022-09-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.